What are the long-term cardiovascular effects ... [Curr Diab Rep. 2008] - PubMed

Supplemental Content

Save items

Related citations in PubMed

Long-term outcomes in patients with type 2 diabetes receiving glimepiride combined with liraglutide or rosiglitazone. [Cardiovasc Diabetol. 2009]
Long-term outcomes in patients with type 2 diabetes receiving glimepiride combined with liraglutide or rosiglitazone.
Sullivan SD, Alfonso-Cristancho R, Conner C, Hammer M, Blonde L. Cardiovasc Diabetol. 2009 Feb 26; 8:12. Epub 2009 Feb 26.
Effect of ramipril and of rosiglitazone on carotid intima-media thickness in people with impaired glucose tolerance or impaired fasting glucose: STARR (STudy of Atherosclerosis with Ramipril and Rosiglitazone). [J Am Coll Cardiol. 2009]
Effect of ramipril and of rosiglitazone on carotid intima-media thickness in people with impaired glucose tolerance or impaired fasting glucose: STARR (STudy of Atherosclerosis with Ramipril and Rosiglitazone).
Lonn EM, Gerstein HC, Sheridan P, Smith S, Diaz R, Mohan V, Bosch J, Yusuf S, Dagenais GR, DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone Medication) and STARR Investigators. J Am Coll Cardiol. 2009 Jun 2; 53(22):2028-35.
Rosiglitazone: can meta-analysis accurately estimate excess cardiovascular risk given the available data? Re-analysis of randomized trials using various methodologic approaches. [BMC Res Notes. 2009]
Rosiglitazone: can meta-analysis accurately estimate excess cardiovascular risk given the available data? Re-analysis of randomized trials using various methodologic approaches.
Friedrich JO, Beyene J, Adhikari NK. BMC Res Notes. 2009 Jan 10; 2:5. Epub 2009 Jan 10.
Review Safety and efficacy of rosiglitazone in the elderly diabetic patient. [Vasc Health Risk Manag. 2009]
Review Safety and efficacy of rosiglitazone in the elderly diabetic patient.
Viljoen A, Sinclair A. Vasc Health Risk Manag. 2009; 5(1):389-95.
Review Cardiovascular risk and cardiometabolic protection: role of glitazones. [J Nephrol. 2008]
Review Cardiovascular risk and cardiometabolic protection: role of glitazones.
Petrazzi L, Grassi D, Polidoro L, D'Aurelio A, Croce G, Properzi G, Tiberti S, Desideri G, Ferri C. J Nephrol. 2008 Nov-Dec; 21(6):826-35.

See reviews... See all...

Recent activity

Clear Turn Off Turn On

What are the long-term cardiovascular effects of treatment with rosiglitazone?
What are the long-term cardiovascular effects of treatment with rosiglitazone?
Curr Diab Rep. 2008 Jun ;8(3):201-2.

PubMed
Caffeine and headaches.
Caffeine and headaches.
Curr Pain Headache Rep. 2008 Aug ;12(4):311-5.

PubMed
Specific genetic markers for detecting subtypes of dengue virus serotype-2 in is...
Specific genetic markers for detecting subtypes of dengue virus serotype-2 in isolates from the states of Oaxaca and Veracruz, Mexico.
BMC Microbiol. 2008 Jul 15 ;8:117.

PubMed
Premature centromere division of the X chromosome in neurons in Alzheimer's dise...
Premature centromere division of the X chromosome in neurons in Alzheimer's disease.
J Neurochem. 2008 Sep ;106(5):2218-23. Epub 2008 Jul 9 .

PubMed
Effectiveness and safety of a prevention-of-flare-progression strategy with pime...
Effectiveness and safety of a prevention-of-flare-progression strategy with pimecrolimus cream 1% in the management of paediatric atopic dermatitis.
J Eur Acad Dermatol Venereol. 2008 Nov ;22(11):1290-301. Epub 2008 Jul 24 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

What are the long-term cardiovascular effects of treatment with rosiglitazone?

Comment on

Publication Types

Publication Types

LinkOut - more resources

Full Text Sources

Supplemental Content

Save items

Related citations in PubMed

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information